Loading clinical trials...

EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis. | Clinical Trials | Clareo Health

RECRUITINGNA

EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis.

NCT05597488•Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

The aim of the current study is to assess if EUS-PPGM could predict the treatment response and outcomes of varices to endoscopic variceal ligation (EVL) in patients with chronic hepatitis. The hypothesis is that a high EUS-PPGM value at 3 months correlates with the presence of varices requiring EVL in patients that have received primary or secondary variceal prophylaxis on 1 year follow-up upper endoscopy.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age between 18 to 75 years old
•Informed consent available
•Suffering from chronic hepatitis induced cirrhosis
•Suffering from oesophageal varices and received EVL as a result of
•1. Primary variceal prophylaxis during a variceal surveillance program on oesophagogastroduodenoscopy (OGD) or
•2. Secondary variceal prophylaxis after EVL in patients with active oesophageal variceal bleeding
•Or bleeding gastric varices that have received endoscopic canoacrylate injection

Exclusion Criteria

•Medical Child-Pugh Class C Uncorrected platelet count \<50,000 INR \> 1.5 (natural) History of hepatic encephalopathy Current or history of hepatocellular carcinoma
•Anatomical Main portal vein thrombosis Anatomic alterations of the hepatic vasculature that prevent access to the portal vein or intrahepatic portion of the hepatic veins (identified at screening and/or during the endoscopic procedure).
•Previous history of spontaneous bacterial peritonitis within the previous three months Portopulmonary hypertension Cardiac decompensation
•Presence of gastric or duodenal ulcers, dieulafoy's lesion or cancers

Locations (1)

Chinese University of Hong Kong

Hong Kong, Hong Kong, China

Key Dates

Start Date

November 1, 2022

Primary Completion Date

October 31, 2026

Completion Date

October 31, 2026

Last Updated

March 20, 2026

Enrollment

160

ESTIMATED participants

Conditions

Cirrhosis Portal

Interventions

EUS guided portal pressure gradient measurement

DEVICE

Contacts

Anthony Teoh

CONTACT

852-35052956 anthonyteoh@surgery.cuhk.edu.hk